Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Plasma Rotation Identified as Critical Factor in Fusion Reactor Particle Distribution and Divertor Efficiency
Advanced Materials Science

Plasma Rotation Identified as Critical Factor in Fusion Reactor Particle Distribution and Divertor Efficiency

Nila Kartika Wati Apr 30, 2026 0

The pursuit of commercial nuclear fusion has long been described as the "holy grail" of clean energy, promising a nearly…

Read More
Biotech & Genetic Research

Cold Plasma Treatment Offers Revolutionary Hope for Peanut Allergy Sufferers

Jia Lissa Apr 29, 2026 0

The persistent challenge of peanut allergies, which has plagued allergy sufferers and scientists for decades, may soon see a transformative…

Read More
Advanced Materials Science

Physicists Use Custom Artificial Intelligence to Reveal Hidden Laws of Non Reciprocal Forces in Complex Dusty Plasma Systems

Nila Kartika Wati Apr 23, 2026 0

In a landmark study that bridges the gap between experimental physics and advanced machine learning, researchers at Emory University have…

Read More
Advanced Materials Science

Plasma Rotation Solves Decades-Old Mystery of Particle Imbalance in Fusion Tokamaks

Nila Kartika Wati Apr 19, 2026 0

For decades, the global scientific community has pursued the "holy grail" of energy: nuclear fusion. By replicating the processes that…

Read More
Advanced Materials Science

Scientists Solve Decades-Old Mystery of Plasma Asymmetry in Fusion Reactors by Identifying Toroidal Rotation as Key Factor

Nila Kartika Wati Apr 11, 2026 0

The pursuit of clean, virtually limitless energy through nuclear fusion has long been hampered by the volatile nature of plasma,…

Read More
Advanced Materials Science

Plasma Rotation Identified as Critical Factor in Solving Tokamak Exhaust Imbalance Puzzle

Nila Kartika Wati Apr 3, 2026 0

For decades, the pursuit of controlled nuclear fusion has been described as the ultimate "holy grail" of energy production—a promise…

Read More

Posts pagination

1 2
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline ExpansionIndiana University School of Medicine Researchers Pioneer Advanced Multiplex Imaging Technique to Unlock the Mysteries of Bone MarrowThe 7 Best Ways to Fund Your Startup Idea: A Comprehensive Guide to Navigating the Capital LandscapeScience News: A Century of Empowering Public Understanding of Science, Medicine, and Technology
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ